An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx)

E. Franceschi (Milan, Italy), S. Aliberti (Milan, Italy), M. Seia (Milan, Italy), L. Porcaro (Milan, Italy), V. Bianchi (Milan, Italy), E. Consalvo (Milan, Italy), A. Corsico (Pavia, Italy), I. Ferrarotti (Pavia, Italy), M. Gaffuri (Milan, Italy), L. Roncoroni (Milan, Italy), B. Vigone (Milan, Italy), A. Gramegna (Milan, Italy), M. Contarini (Milan, Italy), F. Amati (Milan, Italy), N. Borsa (Milan, Italy), F. Nava (Milan, Italy), N. Vanoni (Milan, Italy), A. Bellofiore (Milan, Italy), C. Del Monaco (Milan, Italy), L. Terranova (Milan, Italy), M. Oriano (Milan, Italy), L. Cariani (Milan, Italy), F. Caprioli (Milan, Italy), M. Nosotti (Milan, Italy), F. Blasi (Milan, Italy)

Source: International Congress 2018 – New methods for diagnosing and treating lung diseases
Session: New methods for diagnosing and treating lung diseases
Session type: Oral Presentation
Number: 3270
Disease area: Respiratory infections

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Franceschi (Milan, Italy), S. Aliberti (Milan, Italy), M. Seia (Milan, Italy), L. Porcaro (Milan, Italy), V. Bianchi (Milan, Italy), E. Consalvo (Milan, Italy), A. Corsico (Pavia, Italy), I. Ferrarotti (Pavia, Italy), M. Gaffuri (Milan, Italy), L. Roncoroni (Milan, Italy), B. Vigone (Milan, Italy), A. Gramegna (Milan, Italy), M. Contarini (Milan, Italy), F. Amati (Milan, Italy), N. Borsa (Milan, Italy), F. Nava (Milan, Italy), N. Vanoni (Milan, Italy), A. Bellofiore (Milan, Italy), C. Del Monaco (Milan, Italy), L. Terranova (Milan, Italy), M. Oriano (Milan, Italy), L. Cariani (Milan, Italy), F. Caprioli (Milan, Italy), M. Nosotti (Milan, Italy), F. Blasi (Milan, Italy). An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx). 3270

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
How to make the diagnosis: the easy one, the difficult one
Source: Annual Congress 2007 - PG4 - Paediatric respiratory medicine: cystic fibrosis – the basics
Year: 2007



Relation between pulmonary function tests (PFTs) and severe asthma difficult to control
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020


Idiopathic pulmonary fibrosis: tracking the true occurrence is challenging
Source: Eur Respir J 2015; 46: 604-606
Year: 2015


Diagnostic procedures to detect the causes of hypoxic respiratory failure: is being less invasive necessarily better?
Source: Annual Congress 2006 - PG6 - Respiratory failure: noninvasive ventilation and techniques of diagnosis for hypoxic respiratory failure
Year: 2006

Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features
Source: Eur Respir J 2006; 27: 143-150
Year: 2006



Age at diagnosis and degree of pulmonary function tests disturbances in hypersensitivity pneumonitis (HP) patients
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010

Can AI help in detecting respiratory diseases with incomplete lung function data?
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021


Seasonal epidemiology and clinical manifestations of interstitial lung diseases (ILD) as an important criterion for differential diagnosis viral pneumonia with pulmonary arterial hypertention (PAH) associated with severe COVID-19.
Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends
Year: 2021


The use of imaging to establish the cause of a complex case of respiratory failure
Source: Virtual Congress 2020 – Airway diseases
Year: 2020


Lung ultrasound as useful tool to diagnose pulmonary atelectasis in children affected by neuromuscular disease
Source: International Congress 2018 – Evaluation of COPD and various diseases by different imaging modalities
Year: 2018

Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?
Source: Eur Respir Rev, 30 (162) 210103; 10.1183/16000617.0103-2021
Year: 2021



Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Source: Eur Respir J 2007; 30: 835-839
Year: 2007



Ability of chest radiograph (CXR) scores and lung function tests to detect abnormalities in infants with cystic fibrosis (CF)
Source: Eur Respir J 2005; 26: Suppl. 49, 405s
Year: 2005

Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients?
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

Surgical lung biopsy for interstitial lung disease: when considered necessary, should these be done in larger and experienced centres only?
Source: Eur Respir J, 53 (2) 1900023; 10.1183/13993003.00023-2019
Year: 2019



Laboratory testing of individuals with severe α1-antitrypsin deficiency in three European centres
Source: Eur Respir J 2010; 35: 960-968
Year: 2010



The airspace dimension test – A new way to diagnose emphysema?
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014

The progressive fibrotic phenotype in ILDs: can it be reliably recognised at baseline evaluation?
Source: International Congress 2019 – Lumping and splitting of fibrotic interstitial lung diseases
Year: 2019


Severe heterogeneous emphysema treated unilaterally with endobronchial coils in patients with bilaterally incomplete fissures. Aiming for long lasting endoscopic lung volume reduction (ELVR); is effectiveness sustained at one year follow-up?
Source: International Congress 2014 – Bronchoscopic treatment of emphysema: valves, coils and other
Year: 2014